SOX2 and breast cancer: Beyond the Wnt/β-catenin pathway, a well-established regulator of cancer stemness (41), we analyzed the expression of core pluripotency factors, including Nanog, KLF4, LGR5, and Sox2, which are critical for maintaining self-renewal, tumorigenicity, and therapy resistance in breast cancer stem cells (42–45).